IMPROVEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PURPOSES

Recombinant human serum albumin (OsrHSA) has emerged as a substantial innovation in the sector of biopharmaceuticals, supplying promising progress across a variety of health-related and industrial applications. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, much more trusted choice for therapeutic use